The Goizueta Directors Institute at Emory University.

AuthorIde, R. William

Now in its second year, the Goizueta Directors Institute at Emory University has created a unique forum for board members and officers of publicly traded companies. The Institute seeks to be as dynamic as the corporate governance environment in which it operates--keeping corporate leaders on the cutting edge of governance and regulatory issues. Thus, while last year's Institute emphasized "Corporate Governance for Competitive Advantage" and the new world of corporate governance regulation, this year's Institute addressed "Creating a New Culture: Balancing Director Oversight and Management Entrepreneurship," focusing on the impact of corporate governance reforms on companies and whether the new regulatory environment has gone too far in imposing governance requirements.

Through the Institute, Emory University has sought to produce superior discussion among directors and well-known corporate governance thought leaders. As before, invitations to the Institute were limited to directors and officers of publicly-traded corporations to allow for fresh perspectives from both presenters and their peers. This format promoted a frank and focused exchange on the issues that most directly impact organizations. During the intensive two-day period, attendees heard proven success stories from officers, directors, and other corporate leaders who have achieved the necessary balance of oversight and entrepreneurship in key governance areas and have created the right culture for today's environment. Discussions among panelists and attendees yielded both practical advice that attendees could take back to their respective companies, as well as thought leadership discussions designed to influence corporate governance policy on multiple levels.

...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT